BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24210583)

  • 1. Chorioamnionitis and bronchopulmonary dysplasia in evolution.
    Lands LC
    Paediatr Respir Rev; 2014 Mar; 15(1):47-8. PubMed ID: 24210583
    [No Abstract]   [Full Text] [Related]  

  • 2. Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia--the case in favour.
    Thomas W; Speer CP
    Paediatr Respir Rev; 2014 Mar; 15(1):49-52. PubMed ID: 24128984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia.
    Kent A; Dahlstrom JE
    J Paediatr Child Health; 2004 Jul; 40(7):356-9. PubMed ID: 15228562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chorioamnionitis, lung function and bronchopulmonary dysplasia in prematurely born infants.
    Prendergast M; May C; Broughton S; Pollina E; Milner AD; Rafferty GF; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F270-4. PubMed ID: 21097839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of histological chorioamnionitis and antenatal steroids on neonatal outcome in preterm infants born at less than thirty-four weeks' gestation.
    Ahn HM; Park EA; Cho SJ; Kim YJ; Park HS
    Neonatology; 2012; 102(4):259-64. PubMed ID: 22907714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PREDICTORS OF FORMATION OF NEW FORMS--OF BRONCHOPULMONARY DYSPLASIA AT THE PRENATAL STAGE].
    Loginova OL; Senatorova GS
    Lik Sprava; 2014; (9-10):113-8. PubMed ID: 26492786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenic factors in bronchopulmonary dysplasia].
    Figueras Aloy J; Vilanova Juanola JM; Molina González J; Jiménez González R
    An Esp Pediatr; 1991 Jul; 35(1):36-40. PubMed ID: 1772170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary β-2-microglobulin as an alternative marker for fetal inflammatory response and development of bronchopulmonary dysplasia in premature infants.
    Shima Y; Nishimaki S; Nakajima M; Kumasaka S; Migita M
    J Perinatol; 2011 May; 31(5):330-4. PubMed ID: 21127468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia.
    Kewitz G; Wudel S; Hopp H; Hopfenmüller W; Vogel M; Roots I
    J Perinat Med; 2008; 36(4):359-64. PubMed ID: 18598128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammation and bronchopulmonary dysplasia].
    Lopez E; Jarreau PH
    Med Sci (Paris); 2013 Oct; 29(10):823-5. PubMed ID: 24148114
    [No Abstract]   [Full Text] [Related]  

  • 11. That chorioamnionitis is a risk factor for bronchopulmonary dysplasia--the case against.
    Lacaze-Masmonteil T
    Paediatr Respir Rev; 2014 Mar; 15(1):53-5. PubMed ID: 24120077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In utero growth retardation and bronchopulmonary dysplasia].
    Zana-Taïeb E; Jarreau PH
    Med Sci (Paris); 2013 Oct; 29(10):826-8. PubMed ID: 24148115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neonatal consequences of preterm premature rupture of membrane (PPROM) at 24-34 WG: 118 singleton pregnancies].
    Nicaise C; Gire C; Fagianelli P; Debriere R; Thomachot L; d'Ercole C; Boubli L
    J Gynecol Obstet Biol Reprod (Paris); 2002 Dec; 31(8):747-54. PubMed ID: 12592194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD.
    Fukunaga S; Ichiyama T; Maeba S; Okuda M; Nakata M; Sugino N; Furukawa S
    Pediatr Pulmonol; 2009 Mar; 44(3):267-72. PubMed ID: 19205055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of bronchopulmonary dysplasia.
    May C; Patel S; Kennedy C; Pollina E; Rafferty GF; Peacock JL; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2011 Nov; 96(6):F410-6. PubMed ID: 21362700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemoid reaction and bronchopulmonary dysplasia: a primary inflammatory mechanism?
    Zanardo V; Vedovato S; Trevisanuto D; Chiarelli S
    Pediatrics; 2005 Nov; 116(5):1260-1; author reply 1261. PubMed ID: 16264021
    [No Abstract]   [Full Text] [Related]  

  • 17. Chorioamnionitis and prematurity: a critical review.
    Martinelli P; Sarno L; Maruotti GM; Paludetto R
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():29-31. PubMed ID: 22958008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chorioamnionitis and ontogeny of circulating prostaglandin and thromboxane in preterm infants.
    Natarajan G; Glibetic M; Thomas RL; Aranda JV
    Am J Perinatol; 2008 Sep; 25(8):491-7. PubMed ID: 18726836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal factors and the development of bronchopulmonary dysplasia.
    Jobe AH
    Semin Neonatol; 2003 Feb; 8(1):9-17. PubMed ID: 12667826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filamin A mutation may be associated with diffuse lung disease mimicking bronchopulmonary dysplasia in premature newborns.
    Lord A; Shapiro AJ; Saint-Martin C; Claveau M; Melançon S; Wintermark P
    Respir Care; 2014 Nov; 59(11):e171-7. PubMed ID: 25053830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.